Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Other Non-Current Assets (2016 - 2025)

Lisata Therapeutics' Other Non-Current Assets history spans 13 years, with the latest figure at $23000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 85.62% year-over-year to $23000.0; the TTM value through Dec 2025 reached $23000.0, down 85.62%, while the annual FY2025 figure was $23000.0, 85.62% down from the prior year.
  • Other Non-Current Assets reached $23000.0 in Q4 2025 per LSTA's latest filing, roughly flat from $23000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $449000.0 in Q1 2023 to a low of $23000.0 in Q3 2025.
  • Average Other Non-Current Assets over 3 years is $224250.0, with a median of $223500.0 recorded in 2024.
  • Peak YoY movement for Other Non-Current Assets: crashed 35.41% in 2024, then tumbled 88.56% in 2025.
  • A 3-year view of Other Non-Current Assets shows it stood at $332000.0 in 2023, then plummeted by 51.81% to $160000.0 in 2024, then tumbled by 85.62% to $23000.0 in 2025.
  • Per Business Quant, the three most recent readings for LSTA's Other Non-Current Assets are $23000.0 (Q4 2025), $23000.0 (Q3 2025), and $70000.0 (Q2 2025).